Copyright
        ©The Author(s) 2015.
    
    
        World J Gastroenterol. Jul 21, 2015; 21(27): 8249-8255
Published online Jul 21, 2015. doi: 10.3748/wjg.v21.i27.8249
Published online Jul 21, 2015. doi: 10.3748/wjg.v21.i27.8249
            Table 1 Clinical trials of antiviral therapy after curative treatment for hepatitis B virus-related hepatocellular carcinoma
        
    | Effects of antiviral therapy | ||||||
| Author | Year | Study design | Treatment | Adjuvant therapy | Tumor-free survival | Overall survival | 
| Interferon | ||||||
| Sun et al[39] | 2006 | RCT | Resection | Inteferon-α | Postponed | Improved | 
| Lo et al[37] | 2007 | RCT | Resection | Inteferon-α2b | Not significant | Improved in stage III/IVA patients | 
| Chen et al[42] | 2012 | RCT | Resection | Inteferon-α2b | Not significant | Not significant | 
| Nucleos(t)ide analogues | ||||||
| Kubo et al[45] | 2007 | Prospective cohort | Resection | LAM (with ADV rescue) | Improved | ND | 
| Kuzuya et al[48] | 2007 | Retrospective cohort | Resection or RFA | LAM (with ADV rescue) | Not significant | Improved (tendency) | 
| Yoshida et al[49] | 2008 | Retrospective cohort | RFA | LAM (with ADV rescue) | Not significant | Not significant | 
| Chuma et al[11] | 2009 | Retrospective cohort | Resection or RFA | LAM (with ADV rescue) or ETV | Improved | ND | 
| Koda et al[50] | 2009 | Cohort | Resection or RFA | LAM (with ADV rescue) or ETV | Not significant | Improved | 
| Li et al[51] | 2010 | Prospective cohort | Resection | LAM (with ADV rescue) | Not significant | Improved | 
| Chan et al[52] | 2011 | Retrospective cohort | Resection | LAM or ETV | Improved | Improved | 
| Urata et al[44] | 2012 | Retrospective cohort | Resection | LAM (with ADV rescue) or ETV | Improved | Improved | 
| Wu et al[53] | 2012 | Cohort | Resection | LAM, ETV, telbivudine | Improved | Improved | 
| Su et al[54] | 2013 | Retrospective cohort | Rection | LAM or ETV or Pegylated interferon | Improved | Improved | 
| Ke et al[55] | 2013 | Retrospective cohort | Resection | LAM | Not significant | Improved | 
| Yin et al[56] | 2013 | Cohort including RCT | Resection | LAM (with ADV or ETV rescue) | Improved | Improved | 
| Nishikawa et al[57] | 2014 | Retrospective cohort | Resection or RFA or PEI | LAM (with ADV rescue) or ETV | Not significant | Improved | 
- Citation: Kubo S, Takemura S, Tanaka S, Shinkawa H, Nishioka T, Nozawa A, Kinoshita M, Hamano G, Ito T, Urata Y. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2015; 21(27): 8249-8255
- URL: https://www.wjgnet.com/1007-9327/full/v21/i27/8249.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i27.8249

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        